463
Views
0
CrossRef citations to date
0
Altmetric
Acute Kidney Injury

Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting

, , , , , , , , , , , , , , , , , & show all
Article: 2345747 | Received 16 Jan 2024, Accepted 16 Apr 2024, Published online: 26 Apr 2024

References

  • Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1–9. doi:10.1007/s00134-015-3934-7.
  • Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73. doi:10.1186/cc4915.
  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818. doi:10.1001/jama.294.7.813.
  • White LE, Hassoun HT, Bihorac A, et al. Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg. 2013;75(3):432–438. doi:10.1097/TA.0b013e31829de6cd.
  • Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–257. doi:10.1038/nrneph.2017.2.
  • Hoste E, Bihorac A, Al-Khafaji A, et al. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med. 2020;46(5):943–953. doi:10.1007/s00134-019-05919-0.
  • Cerdá J, Liu KD, Cruz DN, et al. Promoting kidney function recovery in patients with AKI requiring RRT. Clin J Am Soc Nephrol. 2015;10(10):1859–1867. doi:10.2215/CJN.01170215.
  • Coca SG, King JTJr, Rosenthal RA, et al. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010;78(9):926–933. doi:10.1038/ki.2010.259.
  • Mizota T, Dong L, Takeda C, et al. Transient acute kidney injury after major abdominal surgery increases chronic kidney disease risk and 1-year mortality. J Crit Care. 2019;50:17–22. doi:10.1016/j.jcrc.2018.11.008.
  • Koyner JL, Mackey RH, Rosenthal NA, et al. Health care resource utilization and costs of Persistent Severe Acute Kidney Injury (PS-AKI) among hospitalized stage 2/3 AKI patients. Kidney360. 2023;4(3):316–325. doi:10.34067/KID.0005552022.
  • KDIGO working group; KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
  • Ostermann M, Zarbock A, Goldstein S, et al. Recommen­dations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209. doi:10.1001/jamanetworkopen.2020.19209.
  • Bagshaw SM, Al-Khafaji A, Artigas A, et al. External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury. Crit Care. 2021;25(1):185. doi:10.1186/s13054-021-03618-1.
  • Koyner JL, Chawla LS, Bihorac A, et al. Performance of a standardized clinical assay for urinary C-C motif chemokine ligand 14 (CCL14) for persistent severe acute kidney injury. Kidney360. 2022;3(7):1158–1168. doi:10.34067/KID.0008002021.
  • Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Manage Sci. 1963;9(3):458–467. doi:10.1287/mnsc.9.3.458.
  • Koyner JL, Mackey RH, Rosenthal NA, et al. Clinical outcomes of persistent severe acute kidney injury among patients with kidney disease improving global outcomes stage 2 or 3 acute kidney injury. Am J Nephrol. 2022;53(11–12):816–825. doi:10.1159/000528158.
  • Moledina DG, Belliveau O, Yamamoto Y, et al. Variation in best practice measures in patients with severe hospital-acquired acute kidney injury: a multicenter study. Am J Kidney Dis. 2021;77(4):547–549. doi:10.1053/j.ajkd.2020.08.013.
  • Küllmar M, Weiß R, Ostermann M, et al. A multinational observational study exploring adherence with the kidney disease: improving global outcomes recommendations for prevention of acute kidney injury after cardiac surgery. Anesth Analg. 2020;130(4):910–916. doi:10.1213/ANE.0000000000004642.
  • Prowle JR, Artigas A, Bagshaw SM, et al. Serial urinary C-C motif chemokine ligand 14 and risk of persistent severe acute kidney injury. Crit Care Explor. 2023;5(3):e0870. doi:10.1097/CCE.0000000000000870.
  • Albert C, Haase M, Albert A, et al. Biomarker-guided risk assessment for acute kidney injury: time for clinical implementation? Ann Lab Med. 2021;41(1):1–15. doi:10.3343/alm.2021.41.1.1.
  • Massoth C, Küllmar M, Enders D, et al. Comparison of C-C motif chemokine ligand 14 with other biomarkers for adverse kidney events after cardiac surgery. J Thorac Cardiovasc Surg. 2023;165(1):199–207.e2. doi:10.1016/j.jtcvs.2021.03.016.
  • Meersch M, Weiss R, Gerss J, et al. Predicting the development of renal replacement therapy indications by combining the furosemide stress test and chemokine (C-C motif) ligand 14 in a cohort of postsurgical patients. Crit Care Med 2023;51(8):1033–1042.
  • Demirjian S, Chawla LS, Hoste E, et al. CCL14 predicts response to diuretics in patients with moderate to severe AKI. J Am Soc Nephrol. 2022;33:345.
  • Vilaça T, Palmares I, Freitas P, et al. Impact of CCL-14 on clinical practice after severe AKI. Critical Care. 2023;27(S1):P302.
  • Zarbock A. Effect of an intervention to prevent acute kidney injury versus standard care in high-risk patients after major surgery (PrevProgAKI). https://classic.clinicaltrials.gov/ct2/show/study/NCT05275218
  • Anand G, Joshi M. Good publication practice guideline 3: evolving standards for medical writers. Perspect Clin Res. 2019;10(1):4–8. doi:10.4103/picr.PICR_31_18.